The University of Chicago Header Logo

Connection

Amanda Adeleye to Antibodies, Monoclonal, Humanized

Back to Details
This is a "connection" page, showing publications Amanda Adeleye has written about Antibodies, Monoclonal, Humanized.
Amanda Adeleye
Connection Strength
0.144
Antibodies, Monoclonal, Humanized
  1. Primary ovarian insufficiency secondary to chemotherapy with inotuzumab ozogamicin and other agents. J Assist Reprod Genet. 2022 Aug; 39(8):1733-1738.
    View in: PubMed
    Score: 0.144
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.